1 option
Nanoparticle-Based Contrast Agents for CT Imaging, Inflammatory Bowel Disease, and Other Biomedical Applications Derick N Rosario Berrios
- Format:
- Book
- Thesis/Dissertation
- Author/Creator:
- Rosario Berrios, Derick N., author.
- Language:
- English
- Subjects (All):
- Biomedical engineering.
- Medicine.
- Nanotechnology.
- Medical imaging.
- Immunology.
- 0541.
- 0574.
- 0652.
- 0564.
- 0982.
- Local Subjects:
- Biomedical engineering.
- Medicine.
- Nanotechnology.
- Medical imaging.
- Immunology.
- 0541.
- 0574.
- 0652.
- 0564.
- 0982.
- Physical Description:
- 1 electronic resource (189 pages)
- Contained In:
- Dissertations Abstracts International 86-07B
- Place of Publication:
- Ann Arbor : ProQuest Dissertations and Theses, 2024
- Language Note:
- English
- Summary:
- This thesis addresses the challenge of enhancing computed tomography (CT) imaging, particularly for inflammatory bowel disease (IBD), by developing novel nanoparticle-based contrast agents. The research focuses on the limitations of traditional iodinated contrast agents and investigates the potential of nanoparticles to provide superior imaging and therapeutic capabilities. To tackle this problem, the study first explores the advancements in spectral photon counting CT (SPCCT) technology and compares traditional contrast agents with innovative nanoparticle-based agents. PEGylated gold nanoparticles (AuNPs) with core sizes ranging from 5 to 75 nm were synthesized and characterized to assess their impact on gastrointestinal tract imaging in IBD. Despite expectations of size-dependent behavior, the results revealed minimal effect of nanoparticle size on agent progression through the GI tract but demonstrated significantly enhanced contrast and near-total clearance within 24 hours, suggesting promising clinical utility. Additionally, the study develops dextran-coated cerium oxide nanoparticles (Dex-CeNP) as a dual-function agent for both imaging and therapy. The Dex-CeNP, particularly the 5 kDa formulation, showed strong CT contrast, high X-ray attenuation, and superior biocompatibility in vitro. In vivo studies using a DSS-induced colitis mouse model highlighted the enhanced gastrointestinal contrast and prolonged retention at inflammation sites, along with anti-inflammatory properties and effective regulation of TNF-α levels. The conclusions drawn from this investigation underscore the efficacy of nanoparticle-based contrast agents in improving CT imaging and therapy for IBD. The findings pave the way for the broader application of these agents in biomedical imaging and treatment, offering significant advancements over current diagnostic and therapeutic approaches
- Notes:
- Source: Dissertations Abstracts International, Volume: 86-07, Section: B.
- Advisors: Cormode, David P. Committee members: Tsourkas, Andrew; Lennon, Elizabeth M.; Sellmyer, Mark A.
- Ph.D. University of Pennsylvania 2024
- Local Notes:
- School code: 0175
- ISBN:
- 9798302182951
- Access Restriction:
- Restricted for use by site license
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.